Winter 2011- Issue #112
| || |
BCA supports the FDA’s recommendation to revoke Avastin’s use as a treatment for metastatic breast cancer, following clinical trials that showed the drug has no overall survival benefits.
"To proceed" is to move toward an opening without fear. BCA moves into 2011 with several changes afoot, but we remain firmly committed to our mission and our priorities.
BCA founding member Belle Shayer reflects on BCA activism and the 20th anniversary party. Anita Bowen shares her event photos of the activists whose commitment to BCA has made our work possible.
A huge "Thank You!" to our sponsors for making the event possible.